Boston Biomedica Inc. – Consultant Agreement
This Agreement is entered into as of the 31st day of December, 2003, between Boston Biomedica Inc. (“the
Company”) and Richard T. Schumacher (“the Consultant”).
WHEREAS, the Company desires to assure itself that the benefits of the consulting abilities and talents of the
Consultant relative to certain aspects of the Company’s business will be available to the Company;
NOW, THEREFORE, in consideration of the mutual covenants and promises herein contained, the receipt and
sufficiency of which is hereby acknowledged, and intending to be legally bound, it is hereby agreed by and
between the parties as follows:
1. Consulting Engagement. Subject to the terms and conditions of this Agreement, the Company hereby
extends the current engagement of the Consultant as Executive Project Consultant to perform the services set
forth herein, and the Consultant hereby accepts such engagement.
2. Term. The Term of the Consultant’s engagement hereunder shall commence on the date hereof and extend
through December 31, 2004 unless sooner terminated as hereinafter provided.
3. Duties. Subject to the terms and conditions in this Agreement, the Consultant’s duties as Executive Project
Consultant shall be to take an advisory role in directing the Company’s PCT and Source activities and the
Company’s ownership interest in Panacos Pharmaceuticals, Inc. (“Panacos”), each as further described
below, and such other duties as may be assigned to him by the President of the Company or the Board from
time to time. The Consultant shall report to, be specifically accountable to, and shall follow the directions of
the Board of Directors of the Company The Consultant shall devote substantially all his business time and
energy and will use his best efforts to perform his duties hereunder. The Consultant will be given reasonable
access to Company personnel to assist the Consultant in the fulfillment of his duties and